PRODRUGS WITH A TRIDENTATE SELF-IMMOLATIVE LINKER

摘要

The present application provides a compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein L¹, L², L³, n, m, p, X, T, TR, and D are as described herein. Methods of using of these compounds to treat diseases advantageously treatable by drug D are also described.